PFIZER INC - 06 Oct 2022 Form 3 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
10%+ Owner
Signature
/s/ Susan Grant, Assistant Secretary
Issuer symbol
PYXS
Transactions as of
06 Oct 2022
Transactions value $
$0
Form type
3
Filing time
13 Oct 2022, 08:34:29 UTC
Next filing
29 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PYXS Common Stock, $0.001 par value per share 4.14M 06 Oct 2022 Direct
holding PYXS Common Stock, $0.001 par value per share 1.08M 06 Oct 2022 By Pfizer Ventures (US) LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.